Pharmabiz5h
ACT commits Rs. 8.33 crore to the future of rural healthcare in India with Khushi Baby & Medoplus
ACT, an Indian venture philanthropy platform, has committed Rs. 8.33 crore in catalytic grants to Khushi Baby and Medoplus; social startups that are pioneering tech-first solutions to revolutionise ...
Pharmabiz3h
Annovis Bio’s buntanetap receives US patent for treatment and prevention of acute brain or nerve injuries
Annovis Bio Inc., a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), ...
Pharmabiz11h
Health Canada approves MedMira’s Reveal G4 Rapid HIV-1/2 test for point-of-care use
MedMira Inc. (MedMira) announced that it has received the approval from Health Canada for its Reveal Rapid G4 HIV-1/2 Test (Reveal HIV test) for Point-of-Care (POC) use. The Reveal HIV rapid test has ...
Pharmabiz7h
Acadia Pharma seeks European marketing approval for trofinetide for the treatment of Rett syndrome
Acadia Pharmaceuticals Inc., a company is advancing breakthroughs in neuroscience to elevate life, announced that the company has submitted a Marketing Authorization Application (MAA) to the European ...
Pharmabiz8h
Pasithea Therapeutics opens European clinical trial sites and completes initial dosing of cohort 4
Pasithea Therapeutics Corp., a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other ...
Pharmabiz3h
Vistagen reports positive results from exploratory phase 2A study of PH284 in cancer cachexia
Vistagen, a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, announced positive results from an exploratory phase 2A study of PH284 in cancer ...
Pharmabiz7h
GenSight Biologics announces publication of 5-year outcomes for patients treated unilaterally with Lumevoq gene therapy
GenSight Biologics announces publication of 5-year outcomes for patients treated unilaterally with Lumevoq gene therapy: Paris, France Thursday, January 16, 2025, 18:00 Hrs [IST] ...
Pharmabiz11h
Glaukos announces positive clinical updates for its iDose sustained-release procedural pharmaceutical platform
Glaukos announces positive clinical updates for its iDose sustained-release procedural pharmaceutical platform: Aliso Viejo, California Thursday, January 16, 2025, 14:30 Hrs [IST] ...
Pharmabiz11h
Signet begins patient dosing in phase I trial in China for SIGX1094 to treat diffuse gastric cancer and other advanced solid tumours
Signet begins patient dosing in phase I trial in China for SIGX1094 to treat diffuse gastric cancer and other advanced solid tumours: New York Thursday, January 16, 2025, 14:00 Hr ...
Pharmabiz10h
icotec gets US FDA 510(k) clearance for use of BlackArmor implants to treat de novo spinal infections
FDA clearance for the use of BlackArmor implants in the treatment of de novo spinal infections. icotec is honoured to be the first and only company in the United States with FDA 510(k) clearance for ...
Pharmabiz14h
Olfactive Biosolutions granted third dual GLP-1/GIP patent in US to repurpose food molecules for weight management and blood sugar regulation
Mountain View, California Thursday, January 16, 2025, 11:00 Hrs [IST] ...
Pharmabiz17h
With home health monitoring devices, India can improve public health: Tetsuya Yamada
With home health monitoring devices, India can improve public health: Tetsuya Yamada: Nandita Vijayasimha, Bengaluru Thursday, January 16, 2025, 08:00 Hrs [IST] India can establis ...